Affinergy, Inc. To Present At Medtech Insight's "Investment In Innovation" Conference 
10/19/2005 5:08:45 PM

SAN FRANCISCO--(BUSINESS WIRE)--June 8, 2005--Affinergy has announced that it will be presenting at Medtech Insight's Prestigious "Investment In Innovation (In3): A Preview of Early-Stage Medical Technology Companies" Conference, taking place June 14-15, 2005 at The Palace Hotel in San Francisco, CA. Affinergy, Inc., a Duke University spinout, develops site-specific biological & drug delivery systems using biofriendly binders that selectively adhere to proteins, drugs, cells, and other biomaterial surfaces in order to kickstart biology toward an intended outcome. Affinergy is focused in the orthopedic and biologic drug delivery markets with a growing interest in cardiovascular applications. Affinergy's technology was patented at Duke University and has been incubated at Becton Dickinson's research center in Research Triangle Park, North Carolina.